Advanced Progress of the Relationship Between Antihypertensive Drugs and Bone Metabolism
- 1 November 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 80 (11) , 2255-2264
Abstract
Hypertension and osteoporosis are common comorbidities among elderly individuals. Drug therapy has been widely used in clinical practice as the preferred antihypertensive treatment. Therefore, antihypertensive drugs have become some of the most commonly prescribed drugs in healthcare settings. However, antihypertensive drugs have different effects on bone metabolism. The results of animal and clinical studies on the effects of antihypertensive drugs on osteoporosis or fracture risk are controversial and have aroused widespread concern among clinicians. Recent studies found that angiotensin receptor blockers, selective β-adrenergic receptor blockers, and thiazide diuretics might improve bone trabecular number and bone mineral density by stimulating osteoblast differentiation, reducing osteoclast generation, and other mechanism. Furthermore, nonselective β-adrenergic receptor blockers and dihydropyridine calcium channel blockers were found to have no significant relationship with bone mineral density or bone strength, and α-adrenergic receptor blockers and loop diuretics might increase fracture risk by decreasing bone mineral density. This article aimed to review previous animal experiments, clinical studies, and meta-analyses focusing on the effects of different antihypertensive drugs on bone metabolism, and to provide a new approach for the prevention and treatment of osteoporosis.Keywords
This publication has 72 references indexed in Scilit:
- The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly ChineseJournal of Bone and Mineral Metabolism, 2012
- Low dose of propranolol down‐modulates bone resorption by inhibiting inflammation and osteoclast differentiationBritish Journal of Pharmacology, 2011
- Negative magneto resistance in an Si delta-doped GaAs nano-structureJournal of Physics: Conference Series, 2008
- Thiazide Diuretics Directly Induce Osteoblast Differentiation and Mineralized Nodule Formation by Interacting with a Sodium Chloride Co-Transporter in BoneJournal of the American Society of Nephrology, 2007
- Loop Diuretics Increase Bone Turnover and Decrease BMD in Osteopenic Postmenopausal Women: Results From a Randomized Controlled Study With BumetanideJournal of Bone and Mineral Research, 2006
- Fracture risk in patients treated with loop diureticsJournal of Internal Medicine, 2005
- Effects of long‐term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnoverJournal of Internal Medicine, 2005
- Use of α‐blockers and the risk of hip/femur fracturesJournal of Internal Medicine, 2003
- No effect of verapamil on the local bone response to in vivo mechanical loadingJournal of Orthopaedic Research, 2001
- Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitroJournal of Endocrinology, 1997